From Trial to Treatment: Applying the Latest Evidence in mCSPC Management
Please check back later for more content.
Advertisement
Advertisement
Trending on Urology Times
1
Pivotal phase 3 trial launches of rinzimetostat plus darolutamide in mCRPC
2
Ravi Munver, MD, highlights study of first- and second-generation Aquablation systems
3
Genomic Prostate Score may help refine risk assessment in localized prostate cancer
4
First Assist: Early Cystectomy in Non–Muscle Invasive Bladder Cancer, with Matvey Tsivian, MD
5